PF-06743649
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-06743649, covering 2015-01-19 to 2016-11-11. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. [Phase 1]